Seems like everywhere you go, medical device firms fret that venture capitalists eager to seek a quick return on investment are eschewing investments in the industry because of regulatory uncertainty and the burden of the healthcare reform law.
Seems like everywhere you go, medical device firms fret that venture capitalists eager to seek a quick return on investment are eschewing investments in the industry because of regulatory uncertainty and the burden of the healthcare reform law.